{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:26:45Z","timestamp":1782602805923,"version":"3.54.5"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Chinese National Key Technology R&D Program, Ministry of Science and Technology","award":["2021YFC2501300"],"award-info":[{"award-number":["2021YFC2501300"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520022"],"award-info":[{"award-number":["Z201100005520022"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Science","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-038"],"award-info":[{"award-number":["2022-PUMCH-A-038"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["D-009"],"award-info":[{"award-number":["D-009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cigarette smoking is an established risk factor for autoimmune diseases. However, whether smoking plays a clear role in thrombotic APS (TAPS) has not been determined. We aimed to investigate the effects of smoking on the clinical characteristics and prognosis of TAPS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a prospective cohort study from 2013 to 2022. During the study period, 297 patients were diagnosed with TAPS, including 82 smokers and 215 non-smokers. After propensity score matching, 57 smokers and 57 non-smokers matched by age and sex were analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, smokers with TAPS had more cardiovascular risk factors than non-smokers, including hypertension (36.59% vs 14.42%, P &amp;lt;\u20090.001), obesity (15.85% vs 7.44%, P =\u20090.029), dyslipidaemia (64.63% vs 48.37%, P =\u20090.012) and hyperhomocysteinaemia (62.20% vs 36.28%, P &amp;lt;\u20090.001). Arterial thrombotic events were more common in smokers at diagnosis (62.20% vs 46.05%, P\u2009=\u20090.013), especially myocardial infarction, visceral thrombosis and peripheral vascular thrombosis. After matching, smokers showed balanced cardiovascular risk factors with non-smokers at baseline, but retained a higher prevalence of arterial thrombosis (59.65% vs 33.33%, P =\u20090.005), mainly distributed in cerebral vascular, cardiovascula and retinal vascular territories. During follow-up, smokers presented a tendency for more recurrent arterial thrombosis and less recurrent venous thrombosis. Smokers had significantly poorer outcomes for organ damage with higher Damage Index for APS score (median 2.00 vs 1.00, P =\u20090.008), especially in the cardiovascular (26.32% vs 3.51%, P =\u20090.001), gastrointestinal (15.79% vs 1.75%, P =\u20090.016) and ophthalmologic (10.53% vs 00.00%, P =\u20090.027) systems.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Smoking is related to increased arterial events and poor prognosis in TAPS patients. Patients with TAPS should be fully encouraged to avoid smoking.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead498","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T17:39:17Z","timestamp":1695404357000},"page":"1917-1922","source":"Crossref","is-referenced-by-count":8,"title":["Effect of smoking on thrombotic antiphospholipid syndrome: a 10-year prospective cohort study"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4405-7984","authenticated-orcid":false,"given":"Hui","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-1806","authenticated-orcid":false,"given":"Yu","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Han","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology , Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital , Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4252-2889","authenticated-orcid":false,"given":"Meng-Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology , Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital , Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1511-7952","authenticated-orcid":false,"given":"Xin-Ping","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology , Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital , Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-2318","authenticated-orcid":false,"given":"Xiao-Feng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology , Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital , Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology , Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital , Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-2858","authenticated-orcid":false,"given":"Jiu-Liang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology , Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital , Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"2024070114090309000_kead498-B1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2024070114090309000_kead498-B2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"2024070114090309000_kead498-B3","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garcia","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2024070114090309000_kead498-B4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41584-018-0032-6","article-title":"Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?","volume":"14","author":"Meroni","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2024070114090309000_kead498-B5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2024070114090309000_kead498-B6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11926-015-0556-6","article-title":"Organ damage and quality of life in antiphospholipid syndrome","volume":"18","author":"Alba","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"2024070114090309000_kead498-B7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024070114090309000_kead498-B8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.thromres.2013.11.012","article-title":"Risk factors for arterial thrombosis in antiphospholipid syndrome","volume":"133","author":"Matyja-Bednarczyk","year":"2014","journal-title":"Thromb Res"},{"key":"2024070114090309000_kead498-B9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fpubh.2020.00237","article-title":"Trends in Disease Burden Attributable to Tobacco in China, 1990-2017: findings From the Global Burden of Disease Study 2017","volume":"8","author":"Wen","year":"2020","journal-title":"Front Public Health"},{"key":"2024070114090309000_kead498-B10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-205159","article-title":"Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus","volume":"74","author":"Gustafsson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024070114090309000_kead498-B11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.semarthrit.2018.02.003","article-title":"The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis","volume":"48","author":"Schiffenbauer","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2024070114090309000_kead498-B12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001402","article-title":"Cigarette smoking patterns preceding primary Sjogren's syndrome","volume":"6","author":"Mofors","year":"2020","journal-title":"RMD Open"},{"key":"2024070114090309000_kead498-B13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/rheumatology\/kei240","article-title":"The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis","volume":"45","author":"Manfredsdottir","year":"2006","journal-title":"Rheumatology"},{"key":"2024070114090309000_kead498-B14","author":"Barbhaiya"},{"key":"2024070114090309000_kead498-B15","doi-asserted-by":"crossref","first-page":"918368","DOI":"10.1155\/2012\/918368","article-title":"Adult current smoking: differences in definitions and prevalence estimates\u2013NHIS and NSDUH, 2008","volume":"2012","author":"Ryan","year":"2012","journal-title":"J Environ Public Health"},{"key":"2024070114090309000_kead498-B16","first-page":"1","article-title":"Quantification and chemical markers of tobacco-exposure","volume":"70","author":"Prignot","year":"1987","journal-title":"Eur J Respir Dis"},{"key":"2024070114090309000_kead498-B17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0961203315576858","article-title":"Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS)","volume":"24","author":"Amigo","year":"2015","journal-title":"Lupus"},{"key":"2024070114090309000_kead498-B18","first-page":"386","article-title":"The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome","volume":"55","author":"Zhao","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2024070114090309000_kead498-B19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"2024070114090309000_kead498-B20","first-page":"2018","article-title":"Risk factors associated with thrombosis in patients with antiphospholipid antibodies","volume":"28","author":"Hansen","year":"2001","journal-title":"J Rheumatol"},{"key":"2024070114090309000_kead498-B21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"2024070114090309000_kead498-B22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski","year":"2009","journal-title":"J Rheumatol"},{"key":"2024070114090309000_kead498-B23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/1076029618755946","article-title":"Identifying additional risk factors for thrombosis and pregnancy morbidities among antiphospholipid antibodies carriers","volume":"24","author":"Zuo","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"2024070114090309000_kead498-B24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/jth.14427","article-title":"Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation","volume":"17","author":"Hisada","year":"2019","journal-title":"J Thromb Haemost"},{"key":"2024070114090309000_kead498-B25","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.3390\/ijms21249551","article-title":"Genetic factors in antiphospholipid syndrome: preliminary experience with whole exome sequencing","volume":"21","author":"Barinotti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024070114090309000_kead498-B26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"2024070114090309000_kead498-B27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrcardio.2013.8","article-title":"The biology behind the atherothrombotic effects of cigarette smoke","volume":"10","author":"Csordas","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2024070114090309000_kead498-B28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0961203307081847","article-title":"Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome","volume":"16","author":"de Souza","year":"2007","journal-title":"Lupus"},{"key":"2024070114090309000_kead498-B29","first-page":"2161","article-title":"Impact of cardiovascular risk factors in antiphospholipid syndrome: an observational study from the Spanish national registry","volume":"40","author":"Moreno-Torres","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2024070114090309000_kead498-B30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/ard.2010.142042","article-title":"Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study","volume":"70","author":"Ruffatti","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024070114090309000_kead498-B31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0042-1757330","article-title":"Erratum: arterial thrombosis in patients with antiphospholipid syndrome: a review and meta-analysis","volume":"47","author":"Aibar","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"2024070114090309000_kead498-B32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJM197609092951101","article-title":"Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events","volume":"295","author":"Cryer","year":"1976","journal-title":"N Engl J Med"},{"key":"2024070114090309000_kead498-B33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024070114090309000_kead498-B34","doi-asserted-by":"crossref","first-page":"100788","DOI":"10.1016\/j.blre.2020.100788","article-title":"Arterial thrombosis in antiphospholipid syndrome (APS): clinical approach and treatment. A systematic review","volume":"48","author":"Cheng","year":"2021","journal-title":"Blood Rev"},{"key":"2024070114090309000_kead498-B35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"2024070114090309000_kead498-B36","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/cvr\/cvz288","article-title":"B cell-derived anti-beta 2 glycoprotein I antibody contributes to hyperhomocysteinaemia-aggravated abdominal aortic aneurysm","volume":"116","author":"Shao","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2024070114090309000_kead498-B37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0021-9150(96)05820-0","article-title":"Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers","volume":"124","author":"Fickl","year":"1996","journal-title":"Atherosclerosis"},{"key":"2024070114090309000_kead498-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-016-8565-4","article-title":"Anti-phospholipid antibodies and smoking: an overview","volume":"53","author":"Binder","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024070114090309000_kead498-B39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2024070114090309000_kead498-B40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1465-9921-15-49","article-title":"Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure","volume":"15","author":"Morissette","year":"2014","journal-title":"Respir Res"},{"key":"2024070114090309000_kead498-B41","doi-asserted-by":"crossref","first-page":"108365","DOI":"10.1016\/j.mrrev.2021.108365","article-title":"Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer","volume":"787","author":"Caliri","year":"2021","journal-title":"Mutat Res Rev Mutat Res"},{"key":"2024070114090309000_kead498-B42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of smoking cessation with subsequent risk of cardiovascular disease","volume":"322","author":"Duncan","year":"2019","journal-title":"JAMA"},{"key":"2024070114090309000_kead498-B43","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1093\/eurheartj\/ehab578","article-title":"Smoking cessation, but not reduction, reduces cardiovascular disease incidence","volume":"42","author":"Jeong","year":"2021","journal-title":"Eur Heart J"},{"key":"2024070114090309000_kead498-B44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCGENETICS.116.001506","article-title":"Epigenetic signatures of cigarette smoking","volume":"9","author":"Joehanes","year":"2016","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead498\/52076156\/kead498.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/7\/1917\/58378335\/kead498.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/7\/1917\/58378335\/kead498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:00:37Z","timestamp":1719856837000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/7\/1917\/7279118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,9,20]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead498","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2023,9,20]]}}}